There are 859 resources available
90MO - Panitumumab (PAN) vs bevacizumab (BEV) in metastatic colorectal cancer (mCRC) by microsatellite stable (MSS), RAS/BRAF, and HER2 amplification (HER2amp) status: Phase III PARADIGM biomarker study
Presenter: Takeshi Kato
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
358MO - Quality-adjusted life-year and life-year estimates for patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the combined positive score 1-19 subgroup treated with pembrolizumab +/- chemotherapy vs cetuximab-containing regimens
Presenter: Philipp Ivanyi
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
431MO - Cost-effective evaluation of homemade diet recipe in head and neck cancer patients during radiotherapy from low-middle-income group countries
Presenter: Pallavi Kalbande
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Molecular testing/minimal residual disease (MRD)
Presenter: Daniel Shao Weng Tan
Session: Epidermal growth factor receptor (EGFR) mutations in early stage non-small cell lung cancer: Do we know it all?
Resources:
Slides
Webcast
New antibody drug conjugate (ADC) targets on the horizon
Presenter: Do-Youn Oh
Session: Latest updates in drug development
Resources:
Slides
Webcast
432MO - Barriers and facilitators of home-based exercise intervention participation in Indonesian breast cancer patients: A nested qualitative study using COM-B model
Presenter: Yufi Astari
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant 357MO and 358MO
Presenter: Pei Jye Voon
Session: Mini oral session: Head and neck cancer
Resources:
Slides
Webcast
EGFR tyrosine kinase inhibitors (TKIs): Which one? How long? When?
Presenter: Masahiro Tsuboi
Session: Epidermal growth factor receptor (EGFR) mutations in early stage non-small cell lung cancer: Do we know it all?
Resources:
Slides
Webcast
Defining the role of chemotherapy: When and which
Presenter: Smruti Koppikar
Session: Demystifying the treatment of uterine leiomyosarcoma (uLMS)
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Latest updates in drug development
Resources:
Webcast